Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-0808-2025Class II

Aerin Medical VivAer Stylus, REF CAT1785 (individual stylus), and REF CAT500 (5-pack), sterile

Aerin Medical, Inc. / initiated 2024-11-12 / Open, Classified / root cause: manufacturing process

Aerin Medical, Inc. began a recall of Aerin Medical VivAer Stylus, REF CAT1785 (individual stylus), and REF CAT500 (5-pack), sterile on . FDA classified it as Class II and gives the reason as "Some units in a single production lot were programmed incorrectly which will result in the VivAer Stylus being incorrectly recognized as RhinAer Stylus when connected to the Aerin Console". As of , the recall status on record is Open, Classified, and MDM tags the root cause as manufacturing process.

Recall record

Recall number
Z-0808-2025
Classification
Class II
Status
Open, Classified
Initiated
Posted
Recalling firm
Aerin Medical, Inc.
Product
Aerin Medical VivAer Stylus, REF CAT1785 (individual stylus), and REF CAT500 (5-pack), sterile.
Product code
GEI Electrosurgical, Cutting & Coagulation & Accessories
Reason for recall
Some units in a single production lot were programmed incorrectly which will result in the VivAer Stylus being incorrectly recognized as RhinAer Stylus when connected to the Aerin Console.
Root cause tag
manufacturing process
FDA root cause
Under Investigation by firm
Action
The recalling firm issued emails on 11/12/2024. It was necessary to notify several consignees by mail with an "URGENT: MEDICAL DEVICE FIELD NOTICE" letter dated 11/20/2024. The email described the product purchased by the consignee and the reason for recall. The consignee is informed the programmed treatment time will be shorter than the recommended 30 second treatment time for VivAer and the use of the device may result in insufficient treatment. Under the heading "Action to be Taken," it says if a defective device is identified or the consignee wishes to return unused devices within this production lot, they are to return them to the recalling firm, and return instructions are provided. Regarding the mailed "URGENT: MEDICAL DEVICE FIELD NOTICE" letters dated 11/20/2024, they informed the consignee that some of the units in the production lot were programmed incorrectly and, in these cases, the programmed treatment time will be 12 seconds of radiofrequency energy delivery with no cooling time, not the 30 second treatment time for VivAer that includes 18 seconds of energy delivery and 12 seconds of cooling time. The letter also contains instructions to share this notification with all device users within their facility and network to ensure they are aware of this issue. This notification should also be shared with any organization where the potentially affected devices have been transferred. If you need any further information or support concerning this notification, please contact us at [email protected] or call 512-221-9956.
Quantity in commerce
479 units
Distribution
US Nationwide Distribution: AL, AZ, CA, CO, GA, ID, IL, IN, KY LA, MI, MN, NY, NE, NY, OH, OR PA, SC, TN, TX, UT, VA, WA, WI, and WV.
Product codes and lots
Lot #10235, exp. 2026-05-01; UDI (01)08886479300269(17)260501(10)10235

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-0808-2025
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-0808-2025Class IIOngoingVoluntary: Firm initiated